好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Increase of Relapse Rate in Patients with Multiple Sclerosis after In-Vitro Fertilization Is Related to the Use of LHRH Agonists: A Multicenter Retrospective Study in France
MS and Related Diseases
(-)
002
Authors/Disclosures
Laure Michel No disclosure on file
Yohann Foucher No disclosure on file
David P. Fischer No disclosure on file
No disclosure on file
Sandra Vukusic, MD (Hopital Neurologique Pierre Wertheimer) The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Christian Confavreux, MD (Hospital Antiquaille) No disclosure on file
No disclosure on file
Pierre Clavelou, MD, PhD (Hopital Gabriel Montpied) Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Jean C. Ouallet (Dept of Neurology S258) Jean C. Ouallet has nothing to disclose.
Bruno Brochet, MD, FEAN (University of Bordeaux) Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Jean Pelletier, MD, PhD (Dpt of Neurology, CHU Timone) Dr. Pelletier has nothing to disclose.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Christine Lebrun Frenay, MD, FAAN (CRCSEP Neurologie) Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
No disclosure on file
No disclosure on file
Carolyn Fredericks, MD (Yale School of Medicine, Department of Neurology) The institution of Dr. Fredericks has received research support from Alzheimer's Association. The institution of Dr. Fredericks has received research support from National Institute on Aging.
No disclosure on file
David Laplaud No disclosure on file